home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Yellow Card For RNA Interference

 
  June, 7 2006 12:12
your information resource in human molecular genetics
 
     
A study in the 25 May issue of Nature (Vol. 441, No. 7092, pp. 537-541) shows the yellow card to the use of RNA interference in medicine. Mark Kay and his colleagues show that the long-term expression of RNA fragments in mice can end up killing the animals.

In RNA interference, a tiny piece of RNA is added to cells and used to switch off a particular gene; there is great hope that this strategy could be used to treat human disease. The researchers show that a virus can deliver so-called 'short hairpin RNAs' (shRNAs) to mouse liver cells. But of the 49 shRNAs they delivered, 36 of them caused liver injury - with 23 ultimately causing death.

The researchers found that the shRNAs interfered with the function of endogenous liver microRNAs, probably by competing for a limited supply of certain cellular proteins required for processing small RNAs. On the positive side, the group also show that delivering weak doses of one shRNA molecule can combat hepatitis B virus, suggesting that the technique could still work if the RNA dose is carefully controlled.

CONTACT

Mark M A Kay (Stanford University, Stanford, CA, USA)
E-mail: markay@stanford.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.